Cel-Sci
Biotechnology Research11-50 Employees
Learn about working at Cel-Sci. Join LinkedIn today for free. See who you know at Cel-Sci, leverage your professional network, and get hired.
Insights
Phase III Data Launch CEL-SCI Co. has recently launched Phase III data for the therapy from the IT-MATTERS trial, showcasing advancements and potential efficacy that could attract interest from healthcare providers and investors.
Financial Investment Sheets Smith Wealth Management, Inc. recently invested $54,000 into CEL-SCI Co., indicating confidence in the company's prospects and signaling a potential opportunity for cultivating partnerships or collaborations with investors.
Public Offering Funding CEL-SCI Co. secured $7.75 million in public offering financing, providing the company with capital for further growth and development, potentially opening doors for partnerships or services that support this expansion.
Innovative Immunotherapy CEL-SCI Co. is actively developing LEAPS COVID-19 immunotherapy, a cutting-edge approach in the battle against COVID-19, presenting an opportunity for partnerships, licensing agreements, or collaborations in the field of immunotherapy.
Market Positioning Within the biotechnology research industry, CEL-SCI Co. stands out with its focus on innovative therapies and collaborations with reputable institutions, positioning the company as a potential leader in the market and offering opportunities for industry partnerships.
Similar companies to Cel-Sci
Cytovia Therapeutics
18
$10MNorthwest Biotherapeutics
15$10MBavarian Nordic
1.4K$100M$1BNantKwest
51$10M$50M
Cel-Sci Tech Stack
Cel-Sci uses 8 technology products and services including Google Analytics, Microsoft Access, Microsoft Word, and more. Explore Cel-Sci's tech stack below.
- Google AnalyticsAnalytics
- Microsoft AccessDatabase Management Software
- Microsoft WordEditors
- RevsliderMiscellaneous
- CiscoNetwork Hardware
- HSTSSecurity
- Contact Form 7Web Platform Extensions
- OpenRestyWeb Servers
Media & News
Cel-Sci's Email Address Formats
Cel-Sci uses at least 1 format(s):
| Cel-Sci Email Formats | Percentage |
| FLast@cel-sci.com | 90% |
| FirstLast@cel-sci.com | 5% |
| Last@cel-sci.com | 3% |
| FMiddleLast@cel-sci.com | 2% |
Frequently Asked Questions
What is Cel-Sci's stock symbol?
Cel-Sci is a publicly traded company; the company's stock symbol is CVM. What is Cel-Sci's official website and social media links?
Cel-Sci's official website is cel-sci.com and has social profiles on LinkedIn.How much revenue does Cel-Sci generate?
As of August 2024, Cel-Sci's annual revenue reached $657K. What is Cel-Sci's SIC code NAICS code?
Cel-Sci's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Cel-Sci have currently?
As of August 2024, Cel-Sci has approximately 17 employees across 2 continents, including North AmericaAsia. Key team members include Director Of Environmental Monitoring: A. N.Warehouse Manager: M. B.Microbiology And Environmental Monitoring Manager: R. K.. Explore Cel-Sci's employee directory with LeadIQ.What industry does Cel-Sci belong to?
Cel-Sci operates in the Biotechnology Research industry. What technology does Cel-Sci use?
Cel-Sci's tech stack includes Google AnalyticsMicrosoft AccessMicrosoft WordRevsliderCiscoHSTSContact Form 7OpenResty. What is Cel-Sci's email format?
Cel-Sci's email format typically follows the pattern of . Find more Cel-Sci email formats with LeadIQ. How much funding has Cel-Sci raised to date?
As of August 2024, Cel-Sci has raised $11M in funding. The last funding round occurred on Jul 26, 2024 for $11M.
Company Overview
- Website
- cel-sci.com
- SIC Code
- 8731 - Commercial Physical and Biological Research
- Stock Symbol
- CVM
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 11-50
Media & News
Funding & Financials
- $11M
Cel-Sci has raised a total of $11M of funding over 11 rounds. Their latest funding round was raised on Jul 26, 2024 in the amount of $11M.
- $10M
Cel-Sci's revenue is in the range of $10M
Funding & Financials
- $11M
Cel-Sci has raised a total of $11M of funding over 11 rounds. Their latest funding round was raised on Jul 26, 2024 in the amount of $11M.
- $10M
Cel-Sci's revenue is in the range of $10M
Company Leadership
A. N.Director Of Environmental Monitoring
M. B.Warehouse Manager
R. K.Microbiology And Environmental Monitoring Manager- A. L.Scientist Iii
- A. H.Supervisor R&d Analytical Methods
Employee Directory
- C. C.Laboratory Technician
- C. M.General Accountant
- J. C.Associate Immunologist Ii
- J. S.Associate Scientist
- R. C.Research Associate, R&d - Vaccines Heteroconjugates
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
